| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A9 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 5.29e-10 | 296 | 71 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A9 SLC45A3 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 9.76e-09 | 119 | 71 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A9 SLC45A3 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 5.99e-08 | 150 | 71 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A9 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 1.07e-07 | 477 | 71 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 7.08e-07 | 207 | 71 | 8 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 7.34e-07 | 208 | 71 | 8 | GO:0005342 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A9 SLC26A7 SLC45A3 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 1.17e-06 | 301 | 71 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM4 PIEZO2 SLC12A9 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 2.92e-06 | 1180 | 71 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | thyroid hormone transmembrane transporter activity | 3.56e-06 | 9 | 71 | 3 | GO:0015349 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM4 PIEZO2 SLC12A9 SLC26A7 SLC45A3 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 3.82e-06 | 793 | 71 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | transporter activity | TRPM4 PIEZO2 SLC12A9 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 9.02e-06 | 1289 | 71 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 9.33e-06 | 293 | 71 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM4 SLC12A9 SLC26A7 SLC45A3 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 1.34e-05 | 758 | 71 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM4 PIEZO2 SLC12A9 SLC45A3 PKD1L1 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 2.11e-05 | 664 | 71 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.83e-05 | 17 | 71 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.61e-05 | 105 | 71 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | L-tyrosine transmembrane transporter activity | 3.73e-05 | 3 | 71 | 2 | GO:0005302 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPM4 SLC12A9 SLC45A3 PKD1L1 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 7.13e-05 | 627 | 71 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 9.37e-05 | 25 | 71 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 1.19e-04 | 27 | 71 | 3 | GO:0023026 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.19e-04 | 71 | 71 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.47e-04 | 29 | 71 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.99e-04 | 81 | 71 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.02e-04 | 151 | 71 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.58e-04 | 171 | 71 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 4.17e-04 | 41 | 71 | 3 | GO:0023023 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 4.48e-04 | 42 | 71 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | CD4 receptor binding | 6.72e-04 | 11 | 71 | 2 | GO:0042609 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 6.72e-04 | 11 | 71 | 2 | GO:0032395 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 7.06e-04 | 49 | 71 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 9.48e-04 | 13 | 71 | 2 | GO:0015173 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.03e-03 | 125 | 71 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 1.27e-03 | 15 | 71 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.31e-03 | 465 | 71 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.45e-03 | 16 | 71 | 2 | GO:0008242 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 2.27e-03 | 20 | 71 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 2.27e-03 | 20 | 71 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.23e-03 | 83 | 71 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.23e-03 | 171 | 71 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | chloride channel activity | 3.57e-03 | 86 | 71 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 4.06e-03 | 90 | 71 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 4.13e-03 | 27 | 71 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.76e-03 | 29 | 71 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 5.42e-03 | 31 | 71 | 2 | GO:0030247 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 5.42e-03 | 31 | 71 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | peptide binding | 5.48e-03 | 318 | 71 | 5 | GO:0042277 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.80e-03 | 459 | 71 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.91e-03 | 103 | 71 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | taste receptor activity | 6.13e-03 | 33 | 71 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.88e-03 | 35 | 71 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IGF2R RAMP3 HTR4 OR2B2 OR1I1 HLA-DRB1 HLA-DRB5 TAS1R2 GPRC5C TAS2R38 GRM1 | 7.94e-03 | 1353 | 71 | 11 | GO:0004888 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 9.26e-03 | 507 | 71 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 9.26e-03 | 507 | 71 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 9.26e-03 | 231 | 71 | 4 | GO:0005085 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 9.35e-03 | 41 | 71 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | channel activity | 1.09e-02 | 525 | 71 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.10e-02 | 526 | 71 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 1.22e-02 | 47 | 71 | 2 | GO:0004712 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 9.86e-07 | 230 | 69 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.44e-06 | 58 | 69 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 3.04e-06 | 120 | 69 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 GRM1 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 8.77e-06 | 410 | 69 | 9 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 GRM1 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 9.12e-06 | 412 | 69 | 9 | GO:0015849 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.76e-05 | 163 | 69 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 1.94e-05 | 16 | 69 | 3 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 1.94e-05 | 16 | 69 | 3 | GO:0002503 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.02e-05 | 167 | 69 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 3.09e-05 | 108 | 69 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 3.34e-05 | 19 | 69 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 4.56e-05 | 21 | 69 | 3 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 4.56e-05 | 21 | 69 | 3 | GO:0002501 | |
| GeneOntologyBiologicalProcess | amino acid transport | 4.83e-05 | 195 | 69 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC26A7 SLC16A2 SLCO1A2 SLC17A8 GRM1 SLC23A1 SLC1A6 SLC36A2 SLC16A10 | 5.27e-05 | 515 | 69 | 9 | GO:0015711 |
| GeneOntologyBiologicalProcess | thyroid hormone generation | 7.82e-05 | 25 | 69 | 3 | GO:0006590 | |
| GeneOntologyBiologicalProcess | thyroid-stimulating hormone secretion | 1.10e-04 | 5 | 69 | 2 | GO:0070460 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPM4 PIEZO2 RAMP3 SLC12A9 SLC26A7 SLCO1A2 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC1A6 SLC36A2 SLC5A3 | 1.54e-04 | 1374 | 69 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.66e-04 | 32 | 69 | 3 | GO:0019886 | |
| GeneOntologyBiologicalProcess | peptide transport | 1.82e-04 | 355 | 69 | 7 | GO:0015833 | |
| GeneOntologyBiologicalProcess | thyroid hormone metabolic process | 1.99e-04 | 34 | 69 | 3 | GO:0042403 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 2.07e-04 | 87 | 69 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | import into cell | RHOQ TRPM4 IGF2R RAMP3 SLC16A2 ITSN1 SLC17A8 GRM1 SLC15A3 SLC1A6 SLC36A2 SLC5A3 | 2.10e-04 | 1074 | 69 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 2.17e-04 | 35 | 69 | 3 | GO:0015813 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 2.36e-04 | 36 | 69 | 3 | GO:0002495 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.78e-04 | 38 | 69 | 3 | GO:0002504 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.69e-04 | 183 | 69 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 4.91e-04 | 46 | 69 | 3 | GO:0051938 | |
| GeneOntologyBiologicalProcess | amide transport | 5.02e-04 | 420 | 69 | 7 | GO:0042886 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 5.43e-04 | 112 | 69 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 5.56e-04 | 48 | 69 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.62e-04 | 208 | 69 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 7.04e-04 | 120 | 69 | 4 | GO:0006835 | |
| GeneOntologyBiologicalProcess | positive regulation of growth hormone secretion | 7.12e-04 | 12 | 69 | 2 | GO:0060124 | |
| GeneOntologyBiologicalProcess | thyroid hormone transport | 8.40e-04 | 13 | 69 | 2 | GO:0070327 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 8.77e-04 | 334 | 69 | 6 | GO:0030072 | |
| GeneOntologyBiologicalProcess | chloride transport | 8.96e-04 | 128 | 69 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 9.69e-04 | 58 | 69 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | peptide secretion | 1.01e-03 | 343 | 69 | 6 | GO:0002790 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.06e-03 | 134 | 69 | 4 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPM4 PIEZO2 SLC12A9 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC36A2 SLC5A3 | 1.11e-03 | 942 | 69 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPM4 PIEZO2 SLC12A9 SLC26A7 PKD1L1 SLC17A8 SLC15A3 FXYD3 SLC23A1 SLC36A2 SLC5A3 | 1.12e-03 | 1115 | 69 | 11 | GO:0034220 |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.16e-05 | 147 | 72 | 6 | GO:0030665 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 2.57e-05 | 17 | 72 | 3 | GO:0042613 | |
| GeneOntologyCellularComponent | MHC protein complex | 9.62e-05 | 26 | 72 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 9.80e-05 | 215 | 72 | 6 | GO:0030662 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | RHOQ GAD2 IGF2R DSG1 SLC26A7 HLA-DRB1 HLA-DRB4 TEX101 HLA-DRB5 LAMP3 SLC17A8 GPRC5C SLC15A3 SLC36A2 | 1.27e-04 | 1307 | 72 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | RHOQ GAD2 IGF2R DSG1 SLC26A7 HLA-DRB1 HLA-DRB4 TEX101 HLA-DRB5 LAMP3 SLC17A8 GPRC5C SLC15A3 SLC36A2 | 1.47e-04 | 1325 | 72 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.60e-04 | 79 | 72 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.67e-04 | 237 | 72 | 6 | GO:0030136 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.37e-04 | 35 | 72 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | G protein-coupled receptor dimeric complex | 2.43e-04 | 7 | 72 | 2 | GO:0038037 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 4.10e-04 | 101 | 72 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 6.06e-04 | 48 | 72 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 6.07e-04 | 112 | 72 | 4 | GO:0032588 | |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 6.31e-04 | 11 | 72 | 2 | GO:0097648 | |
| GeneOntologyCellularComponent | trans-Golgi network | 6.51e-04 | 306 | 72 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | endosome membrane | IGF2R SLC26A7 HLA-DRB1 HLA-DRB4 HLA-DRB5 LAMP3 SLC15A3 SLC36A2 | 1.07e-03 | 602 | 72 | 8 | GO:0010008 |
| GeneOntologyCellularComponent | late endosome | 1.26e-03 | 348 | 72 | 6 | GO:0005770 | |
| GeneOntologyCellularComponent | clathrin-sculpted vesicle | 1.36e-03 | 16 | 72 | 2 | GO:0060198 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.38e-03 | 354 | 72 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.40e-03 | 64 | 72 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.42e-03 | 487 | 72 | 7 | GO:0016324 | |
| GeneOntologyCellularComponent | coated vesicle | 1.50e-03 | 360 | 72 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.79e-03 | 507 | 72 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | basal part of cell | 1.92e-03 | 378 | 72 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | endosome | IGF2R HTR4 SLC26A7 HLA-DRB1 ITSN1 HLA-DRB4 HLA-DRB5 LAMP3 SLC17A8 SLC15A3 SLC36A2 | 2.06e-03 | 1167 | 72 | 11 | GO:0005768 |
| GeneOntologyCellularComponent | late endosome membrane | 3.40e-03 | 179 | 72 | 4 | GO:0031902 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.40e-03 | 293 | 72 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | vacuole | RAMP3 ARHGEF7 HLA-DRB1 HLA-DRB4 HLA-DRB5 LAMP3 LRBA SLC15A3 SLC36A2 | 4.01e-03 | 913 | 72 | 9 | GO:0005773 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.21e-03 | 443 | 72 | 6 | GO:0098791 | |
| GeneOntologyCellularComponent | apical part of cell | 4.23e-03 | 592 | 72 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | membrane protein complex | TRPM4 IGF2R RAMP3 HLA-DRB1 HLA-DRB4 HLA-DRB5 PKD1L1 SLC17A8 DENND5A GRM1 SLC1A6 SLC5A3 | 4.87e-03 | 1498 | 72 | 12 | GO:0098796 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.94e-03 | 320 | 72 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | lysosomal membrane | 5.15e-03 | 462 | 72 | 6 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 5.15e-03 | 462 | 72 | 6 | GO:0098852 | |
| GeneOntologyCellularComponent | apical dendrite | 5.43e-03 | 32 | 72 | 2 | GO:0097440 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 6.18e-03 | 212 | 72 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 6.50e-03 | 110 | 72 | 3 | GO:0030134 | |
| Domain | MHC_II_b_N | 2.44e-06 | 8 | 67 | 3 | PD000328 | |
| Domain | MHC_II_beta | 3.65e-06 | 9 | 67 | 3 | PF00969 | |
| Domain | MHC_II_b_N | 3.65e-06 | 9 | 67 | 3 | IPR000353 | |
| Domain | MHC_II_beta | 3.65e-06 | 9 | 67 | 3 | SM00921 | |
| Domain | MFS_dom | 8.50e-06 | 134 | 67 | 6 | IPR020846 | |
| Domain | MHC_II_a/b_N | 1.56e-05 | 14 | 67 | 3 | IPR014745 | |
| Domain | - | 1.56e-05 | 14 | 67 | 3 | 3.10.320.10 | |
| Domain | GPCR_3 | 5.60e-05 | 21 | 67 | 3 | IPR000337 | |
| Domain | 7tm_3 | 6.47e-05 | 22 | 67 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 6.47e-05 | 22 | 67 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 6.47e-05 | 22 | 67 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 6.47e-05 | 22 | 67 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 6.47e-05 | 22 | 67 | 3 | PS50259 | |
| Domain | GPCR_3_C | 6.47e-05 | 22 | 67 | 3 | IPR017978 | |
| Domain | MFS_1 | 1.68e-04 | 77 | 67 | 4 | PF07690 | |
| Domain | MFS | 1.68e-04 | 77 | 67 | 4 | IPR011701 | |
| Domain | MHC_I/II-like_Ag-recog | 3.40e-04 | 38 | 67 | 3 | IPR011162 | |
| Domain | GDS_CDC24_CS | 3.68e-04 | 39 | 67 | 3 | IPR001331 | |
| Domain | MFS | 6.12e-04 | 108 | 67 | 4 | PS50850 | |
| Domain | C1-set | 9.60e-04 | 54 | 67 | 3 | PF07654 | |
| Domain | NCD3G | 9.64e-04 | 13 | 67 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 9.64e-04 | 13 | 67 | 2 | IPR011500 | |
| Domain | IGc1 | 1.07e-03 | 56 | 67 | 3 | SM00407 | |
| Domain | GPCR_3_CS | 1.12e-03 | 14 | 67 | 2 | IPR017979 | |
| Domain | Ig_C1-set | 1.18e-03 | 58 | 67 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 1.18e-03 | 58 | 67 | 3 | IPR003006 | |
| Domain | IG_MHC | 1.30e-03 | 60 | 67 | 3 | PS00290 | |
| Domain | DH_1 | 1.50e-03 | 63 | 67 | 3 | PS00741 | |
| Domain | RhoGEF | 1.87e-03 | 68 | 67 | 3 | SM00325 | |
| Domain | RhoGEF | 2.03e-03 | 70 | 67 | 3 | PF00621 | |
| Domain | DH_2 | 2.03e-03 | 70 | 67 | 3 | PS50010 | |
| Domain | DH-domain | 2.12e-03 | 71 | 67 | 3 | IPR000219 | |
| Domain | - | 2.12e-03 | 71 | 67 | 3 | 1.20.900.10 | |
| Domain | UPAR_LY6 | 2.31e-03 | 20 | 67 | 2 | PF00021 | |
| Domain | PLAT | 2.55e-03 | 21 | 67 | 2 | PS50095 | |
| Domain | - | 2.55e-03 | 21 | 67 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.55e-03 | 21 | 67 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.55e-03 | 21 | 67 | 2 | IPR001024 | |
| Domain | SH3_9 | 2.77e-03 | 78 | 67 | 3 | PF14604 | |
| Domain | LY6_UPAR | 2.80e-03 | 22 | 67 | 2 | PS00983 | |
| Domain | LY6_UPA_recep-like | 2.80e-03 | 22 | 67 | 2 | IPR016054 | |
| Domain | SH3_1 | 2.86e-03 | 164 | 67 | 4 | PF00018 | |
| Domain | SH3_2 | 3.65e-03 | 86 | 67 | 3 | IPR011511 | |
| Domain | SH3_2 | 3.65e-03 | 86 | 67 | 3 | PF07653 | |
| Domain | SH3 | 7.55e-03 | 216 | 67 | 4 | SM00326 | |
| Domain | SH3 | 7.55e-03 | 216 | 67 | 4 | PS50002 | |
| Domain | ANF_lig-bd_rcpt | 7.79e-03 | 37 | 67 | 2 | IPR001828 | |
| Domain | ANF_receptor | 7.79e-03 | 37 | 67 | 2 | PF01094 | |
| Domain | SH3_domain | 8.05e-03 | 220 | 67 | 4 | IPR001452 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 1.94e-08 | 238 | 54 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 2.99e-08 | 249 | 54 | 10 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.37e-06 | 108 | 54 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.55e-06 | 109 | 54 | 6 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPM4 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 FXYD3 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 7.75e-06 | 681 | 54 | 12 | MM14985 |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 8.58e-06 | 11 | 54 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 8.58e-06 | 11 | 54 | 3 | M22048 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 1.48e-05 | 13 | 54 | 3 | M18928 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPM4 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 FXYD3 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 1.70e-05 | 736 | 54 | 12 | M27287 |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M22023 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M1473 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 1.88e-05 | 14 | 54 | 3 | M10765 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.12e-05 | 43 | 54 | 4 | M12617 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 2.34e-05 | 15 | 54 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 2.34e-05 | 15 | 54 | 3 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 2.34e-05 | 15 | 54 | 3 | M7298 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.04e-05 | 47 | 54 | 4 | M42524 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 7.77e-05 | 22 | 54 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 7.77e-05 | 22 | 54 | 3 | M1467 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 8.91e-05 | 23 | 54 | 3 | M6705 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION | 1.43e-04 | 5 | 54 | 2 | M49011 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.46e-04 | 70 | 54 | 4 | M12294 | |
| Pathway | REACTOME_PD_1_SIGNALING | 1.63e-04 | 28 | 54 | 3 | M18810 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.81e-04 | 29 | 54 | 3 | M6910 | |
| Pathway | PID_CDC42_REG_PATHWAY | 2.00e-04 | 30 | 54 | 3 | M83 | |
| Pathway | KEGG_ASTHMA | 2.00e-04 | 30 | 54 | 3 | M13950 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION | 2.14e-04 | 6 | 54 | 2 | M47665 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 3.76e-04 | 37 | 54 | 3 | M18615 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.76e-04 | 37 | 54 | 3 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.40e-04 | 39 | 54 | 3 | M793 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 4.40e-04 | 39 | 54 | 3 | M16523 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 5.10e-04 | 9 | 54 | 2 | M47629 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 5.11e-04 | 41 | 54 | 3 | M13519 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 7.75e-04 | 11 | 54 | 2 | M930 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 8.14e-04 | 48 | 54 | 3 | M615 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 9.27e-04 | 12 | 54 | 2 | M39331 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 9.27e-04 | 12 | 54 | 2 | MM15476 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 1.03e-03 | 52 | 54 | 3 | M13103 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.03e-03 | 52 | 54 | 3 | MM14743 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.41e-03 | 58 | 54 | 3 | MM15602 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.46e-03 | 15 | 54 | 2 | M39442 | |
| Pathway | WP_ALANINE_AND_ASPARTATE_METABOLISM | 1.46e-03 | 15 | 54 | 2 | MM15960 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.46e-03 | 15 | 54 | 2 | MM15845 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 1.48e-03 | 59 | 54 | 3 | M41812 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.48e-03 | 59 | 54 | 3 | M11215 | |
| Pathway | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | 1.67e-03 | 16 | 54 | 2 | MM14808 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | 2.36e-03 | 19 | 54 | 2 | MM14807 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.43e-03 | 70 | 54 | 3 | MM14824 | |
| Pathway | REACTOME_PD_1_SIGNALING | 2.62e-03 | 20 | 54 | 2 | MM15001 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 2.63e-03 | 72 | 54 | 3 | M3126 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 2.84e-03 | 74 | 54 | 3 | M17386 | |
| Pathway | WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX | 2.89e-03 | 21 | 54 | 2 | M39876 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.00e-03 | 646 | 54 | 8 | MM14962 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 3.07e-03 | 76 | 54 | 3 | M19832 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.18e-03 | 77 | 54 | 3 | M27226 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 3.18e-03 | 77 | 54 | 3 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 3.54e-03 | 80 | 54 | 3 | M800 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.07e-03 | 84 | 54 | 3 | MM14929 | |
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 8.51e-09 | 3 | 72 | 3 | 12358860 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 1428007 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 7652736 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 8.51e-09 | 3 | 72 | 3 | 2023919 | |
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 8.51e-09 | 3 | 72 | 3 | 9500545 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 8.51e-09 | 3 | 72 | 3 | 12121280 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 19811438 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 3099214 | ||
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 8.51e-09 | 3 | 72 | 3 | 15730527 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 20193583 | ||
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 8.51e-09 | 3 | 72 | 3 | 2511168 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 16441501 | ||
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 3.40e-08 | 4 | 72 | 3 | 3476943 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 26740600 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 3.40e-08 | 4 | 72 | 3 | 3020127 | |
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 3.40e-08 | 4 | 72 | 3 | 12144077 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 18520346 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 11782380 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 17910142 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 8.48e-08 | 5 | 72 | 3 | 1970352 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 7645219 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 12392858 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 12209103 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 23152536 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 8.48e-08 | 5 | 72 | 3 | 17507489 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 8.48e-08 | 5 | 72 | 3 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 8.48e-08 | 5 | 72 | 3 | 12144632 | |
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 8.48e-08 | 5 | 72 | 3 | 17182961 | |
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 8.48e-08 | 5 | 72 | 3 | 12202216 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 11082517 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15896200 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 17153701 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 18305173 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 15902698 | ||
| Pubmed | Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. | 1.69e-07 | 6 | 72 | 3 | 20679730 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 11997714 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 1.69e-07 | 6 | 72 | 3 | 19235017 | |
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 1.69e-07 | 6 | 72 | 3 | 14508706 | |
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 18569076 | ||
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 2.96e-07 | 7 | 72 | 3 | 12230470 | |
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 2.96e-07 | 7 | 72 | 3 | 18846964 | |
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 20307907 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 17106278 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 19223392 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 4.73e-07 | 8 | 72 | 3 | 16405603 | |
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 12296785 | ||
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 23729440 | ||
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 23170932 | ||
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 21486766 | ||
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 24505475 | ||
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 15784911 | ||
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 12956878 | ||
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 8450224 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 21085635 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 22808111 | ||
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 3.05e-06 | 14 | 72 | 3 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 3.05e-06 | 14 | 72 | 3 | 1869305 | |
| Pubmed | 3.05e-06 | 14 | 72 | 3 | 17431094 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 8376762 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 8168144 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 3.80e-06 | 15 | 72 | 3 | 22860026 | |
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 7602119 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 1967269 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 9079699 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 3489470 | ||
| Pubmed | 3.80e-06 | 15 | 72 | 3 | 10729169 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 2592019 | ||
| Pubmed | Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma. | 4.23e-06 | 2 | 72 | 2 | 1353478 | |
| Pubmed | Complete cDNA sequences of the HLA-DRB1*14011, *1402, *1403 and *1404 alleles. | 4.23e-06 | 2 | 72 | 2 | 11972886 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21315799 | ||
| Pubmed | H2-EB1 Molecule Alleviates Allergic Rhinitis Symptoms of H2-Eb1 Knockout Mice. | 4.23e-06 | 2 | 72 | 2 | 26714418 | |
| Pubmed | Recruitment of multiple alleles within the Eb recombinational hotspot in murine MHC. | 4.23e-06 | 2 | 72 | 2 | 8268654 | |
| Pubmed | Relationship between the TAS2R38 and TAS1R2 polymorphisms and the dental status in obese children. | 4.23e-06 | 2 | 72 | 2 | 35510485 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12028548 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 1612646 | ||
| Pubmed | Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. | 4.23e-06 | 2 | 72 | 2 | 20064541 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 3150763 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9777332 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 3596674 | ||
| Pubmed | Molecular analysis of the hotspot of recombination in the murine major histocompatibility complex. | 4.23e-06 | 2 | 72 | 2 | 3018929 | |
| Pubmed | Isolation and characterization of a cDNA clone for the murine I-E beta polypeptide chain. | 4.23e-06 | 2 | 72 | 2 | 6324181 | |
| Pubmed | Mouse MHC class II gene E beta 2 is closely related to E beta and to HLA-DR beta. | 4.23e-06 | 2 | 72 | 2 | 2989167 | |
| Pubmed | Sequence analysis of MHC class II Eb cDNAs from H2r and H2p haplotypes. | 4.23e-06 | 2 | 72 | 2 | 8662092 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16140993 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 1918991 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 2106558 | ||
| Pubmed | Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. | 4.23e-06 | 2 | 72 | 2 | 18337592 | |
| Pubmed | Structural organization of the DR subregion of the human major histocompatibility complex. | 4.23e-06 | 2 | 72 | 2 | 3860851 | |
| Pubmed | HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. | 4.23e-06 | 2 | 72 | 2 | 2885840 | |
| Pubmed | Cell type-specific enhancer element associated with a mouse MHC gene, E beta. | 4.23e-06 | 2 | 72 | 2 | 6087163 | |
| Pubmed | Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. | 4.23e-06 | 2 | 72 | 2 | 18832704 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21177998 | ||
| Pubmed | Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15. | 4.23e-06 | 2 | 72 | 2 | 31882398 | |
| Pubmed | HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. | 4.23e-06 | 2 | 72 | 2 | 19487610 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20164547 | ||
| Pubmed | [Linkage of allergic rhinitis with HLA-DRB alleles polymorphism]. | 4.23e-06 | 2 | 72 | 2 | 12541760 | |
| Cytoband | 19q13.31 | 9.58e-04 | 29 | 72 | 2 | 19q13.31 | |
| GeneFamily | Solute carriers | SLC12A9 SLC26A7 SLC45A3 SLC16A2 SLCO1A2 SLC17A8 SLC15A3 SLC23A1 SLC1A6 SLC36A2 SLC16A10 SLC5A3 | 5.75e-10 | 395 | 50 | 12 | 752 |
| GeneFamily | C1-set domain containing | 2.12e-04 | 42 | 50 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 2.43e-04 | 44 | 50 | 3 | 588 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.06e-04 | 66 | 50 | 3 | 722 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 3.97e-03 | 34 | 50 | 2 | 1226 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.45e-03 | 36 | 50 | 2 | 823 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 9.44e-03 | 53 | 50 | 2 | 103 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 1.68e-05 | 196 | 72 | 6 | M3243 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.88e-05 | 200 | 72 | 6 | M9181 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 2.55e-05 | 21 | 72 | 3 | M41167 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 3.83e-05 | 137 | 72 | 5 | M2397 | |
| CoexpressionAtlas | lung | 2.57e-05 | 182 | 68 | 6 | lung | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | TMEM171 MYH11 SLC16A2 COBLL1 GPRC5C PC HNMT SLC23A1 ARHGEF6 SLC16A10 SLC5A3 | 4.32e-05 | 799 | 68 | 11 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 7.38e-07 | 197 | 71 | 6 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 7.38e-07 | 197 | 71 | 6 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.34e-06 | 151 | 71 | 5 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-06 | 156 | 71 | 5 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 173 | 71 | 5 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 8.65e-06 | 174 | 71 | 5 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-06 | 174 | 71 | 5 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-05 | 186 | 71 | 5 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 1.32e-05 | 190 | 71 | 5 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-05 | 190 | 71 | 5 | 0a944da2aaaef9289b2a4ffe360b0338724fd59b | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 190 | 71 | 5 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.39e-05 | 192 | 71 | 5 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.43e-05 | 193 | 71 | 5 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 1.43e-05 | 193 | 71 | 5 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.46e-05 | 194 | 71 | 5 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 194 | 71 | 5 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.46e-05 | 194 | 71 | 5 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | 343B-Myeloid-Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-05 | 195 | 71 | 5 | 48ba2044d2459c8b0d17bc7deca8d0195ac6a00e | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.50e-05 | 195 | 71 | 5 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | ILEUM-inflamed|ILEUM / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.50e-05 | 195 | 71 | 5 | 661962a8bcd2b69894e889cb0681a5b0cdb8e819 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-05 | 196 | 71 | 5 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 196 | 71 | 5 | 93a5d9b8bcff7d07596ef1f4f2b74f043835fc69 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.54e-05 | 196 | 71 | 5 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 196 | 71 | 5 | 4715f19f844e7244fc4bc446cba7c8088c600fc3 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 1.58e-05 | 197 | 71 | 5 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-05 | 197 | 71 | 5 | 367aaf277c56962c96ddb4de06949fb33fc6170b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-05 | 198 | 71 | 5 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-05 | 198 | 71 | 5 | 3a1707318814dabdec48f91fa6bd223f5b879653 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 199 | 71 | 5 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | tumor_Lung-Myeloid_cells|tumor_Lung / Location, Cell class and cell subclass | 1.65e-05 | 199 | 71 | 5 | a15f7d85efa47245ec6bb398379da1eec9572b75 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 199 | 71 | 5 | b3974190972f173ed331c2242baf583fa3323657 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 1.65e-05 | 199 | 71 | 5 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-05 | 199 | 71 | 5 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 199 | 71 | 5 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 200 | 71 | 5 | ecd2b9a7d464792b77381d0a0bc7030e77ad3581 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.69e-05 | 200 | 71 | 5 | b3f4eb45545f1632dc62f942756a6b81397c18c1 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 200 | 71 | 5 | 3a69149055ac8511eb789dbcc89fd17ccfb2ea6b | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 200 | 71 | 5 | b303553aca8fc021f932b52e88e9ef270d5a4f03 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 200 | 71 | 5 | ec39df7fb4454af629a4a4f6755bd02c9581a2ca | |
| ToppCell | 10x5'-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 1.69e-05 | 200 | 71 | 5 | 4cf663e8a337134aefc302739407eb57392e2bd6 | |
| ToppCell | metastatic_Brain-Myeloid_cells-mo-Mac|metastatic_Brain / Location, Cell class and cell subclass | 1.69e-05 | 200 | 71 | 5 | 8f702d518f652782b0dd6ca3bdd965a79deb61f3 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-05 | 200 | 71 | 5 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 2.04e-05 | 208 | 71 | 5 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.24e-05 | 128 | 71 | 4 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.26e-05 | 134 | 71 | 4 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.22e-05 | 139 | 71 | 4 | 4f4b447e85dda69058d9edbcfe37e55751dd90a6 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-05 | 139 | 71 | 4 | 1cc48af58a2443db3c6798080b9c4bc70000cf87 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.06e-05 | 143 | 71 | 4 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-05 | 150 | 71 | 4 | 3dc23a37dbeb7f9df93683702a7838f7cc3ec9cc | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.07e-04 | 154 | 71 | 4 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 156 | 71 | 4 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 157 | 71 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-04 | 157 | 71 | 4 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-04 | 158 | 71 | 4 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.21e-04 | 159 | 71 | 4 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.34e-04 | 163 | 71 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 166 | 71 | 4 | 75d719617c61409860f298ce91cbe3a0aafa0553 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 168 | 71 | 4 | eba865465feb0f42055bb8f98946050eeb03d177 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 168 | 71 | 4 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 168 | 71 | 4 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 169 | 71 | 4 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.53e-04 | 169 | 71 | 4 | c100a91be9b94bd433a3b172f4a1bfb9d2393003 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.57e-04 | 170 | 71 | 4 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | control|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.60e-04 | 171 | 71 | 4 | 837c1186504f110ccf5b580d9cd4e50ca60c173f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 171 | 71 | 4 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 172 | 71 | 4 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 172 | 71 | 4 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 173 | 71 | 4 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.68e-04 | 173 | 71 | 4 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-04 | 174 | 71 | 4 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 71 | 4 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 175 | 71 | 4 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 176 | 71 | 4 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 1.79e-04 | 176 | 71 | 4 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 176 | 71 | 4 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-04 | 177 | 71 | 4 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-04 | 177 | 71 | 4 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.87e-04 | 178 | 71 | 4 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-04 | 179 | 71 | 4 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.95e-04 | 180 | 71 | 4 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 180 | 71 | 4 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 181 | 71 | 4 | 0bc58c8942491e7ee5b858c5742770df7677532f | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Memory_B_cells|Liver / Manually curated celltypes from each tissue | 1.99e-04 | 181 | 71 | 4 | a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.99e-04 | 181 | 71 | 4 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-04 | 181 | 71 | 4 | 0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4 | |
| ToppCell | MS-mono2-|MS / Condition, Cell_class and T cell subcluster | 2.04e-04 | 182 | 71 | 4 | b5a31df2d26956e83a3afebbdaef953c7bc0d4a0 | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 2.04e-04 | 182 | 71 | 4 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | MS-mono2|MS / Condition, Cell_class and T cell subcluster | 2.04e-04 | 182 | 71 | 4 | 44deaa67b82312139eb83ab93ec41521105b116b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.04e-04 | 182 | 71 | 4 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.08e-04 | 183 | 71 | 4 | 4ba879552e2101a341f3224826d364ac64c72260 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-04 | 183 | 71 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 183 | 71 | 4 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 183 | 71 | 4 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-04 | 184 | 71 | 4 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.12e-04 | 184 | 71 | 4 | 2dc4b2a9970111ed5e2977fc178595a12d7bb59d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 184 | 71 | 4 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 185 | 71 | 4 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| Computational | Genes in the cancer module 186. | 7.44e-05 | 20 | 45 | 3 | MODULE_186 | |
| Computational | Genes in the cancer module 71. | 9.99e-05 | 22 | 45 | 3 | MODULE_71 | |
| Drug | Palladium | 1.05e-06 | 7 | 72 | 3 | ctd:D010165 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; HL60; HT_HG-U133A | 2.89e-06 | 196 | 72 | 7 | 2951_UP | |
| Drug | sodium | TRPM4 SLC12A9 SLC26A7 SLC16A2 SLCO1A2 SLC17A8 LRBA FXYD3 SLC23A1 SLC1A6 SLC36A2 PHC1 SLC16A10 | 7.22e-06 | 944 | 72 | 13 | CID000000923 |
| Drug | ethylglutamate | 1.65e-05 | 16 | 72 | 3 | CID000014241 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 5.71e-06 | 2 | 71 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | cathepsin L1 measurement | 7.31e-06 | 16 | 71 | 3 | EFO_0010619 | |
| Disease | Allergic Reaction | 1.65e-05 | 63 | 71 | 4 | C1527304 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 1.71e-05 | 3 | 71 | 2 | DOID:639 (is_implicated_in) | |
| Disease | Hypersensitivity | 1.75e-05 | 64 | 71 | 4 | C0020517 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 5.68e-05 | 5 | 71 | 2 | EFO_0801672 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 9.78e-05 | 37 | 71 | 3 | EFO_0022252 | |
| Disease | factor VIII measurement | 1.24e-04 | 40 | 71 | 3 | EFO_0004630 | |
| Disease | Bipolar Disorder | 1.50e-04 | 477 | 71 | 7 | C0005586 | |
| Disease | triglycerides in large LDL measurement | 1.54e-04 | 43 | 71 | 3 | EFO_0022319 | |
| Disease | interleukin-21 measurement | 1.58e-04 | 8 | 71 | 2 | EFO_0801724 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0007790 | |
| Disease | X-11381 measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0021228 | |
| Disease | central nervous system non-hodgkin lymphoma | 2.03e-04 | 9 | 71 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0801686 | |
| Disease | CCL19 measurement | 2.54e-04 | 10 | 71 | 2 | EFO_0009415 | |
| Disease | total lipids in medium VLDL | 3.03e-04 | 54 | 71 | 3 | EFO_0022153 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 3.10e-04 | 11 | 71 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | triglycerides in LDL measurement | 3.38e-04 | 56 | 71 | 3 | EFO_0022320 | |
| Disease | anti-Epstein Barr virus antibody measurement | 3.71e-04 | 12 | 71 | 2 | EFO_0009273 | |
| Disease | triglycerides in IDL measurement | 3.75e-04 | 58 | 71 | 3 | EFO_0022149 | |
| Disease | phospholipids in VLDL measurement | 3.94e-04 | 59 | 71 | 3 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 4.14e-04 | 60 | 71 | 3 | EFO_0022314 | |
| Disease | free cholesterol in VLDL measurement | 4.35e-04 | 61 | 71 | 3 | EFO_0022276 | |
| Disease | esophageal squamous cell carcinoma | 4.38e-04 | 13 | 71 | 2 | EFO_0005922 | |
| Disease | triglycerides in medium LDL measurement | 4.56e-04 | 62 | 71 | 3 | EFO_0022322 | |
| Disease | C-C motif chemokine 19 measurement | 5.10e-04 | 14 | 71 | 2 | EFO_0008047 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.16e-04 | 153 | 71 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | cholesterol in large VLDL measurement | 5.24e-04 | 65 | 71 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 5.24e-04 | 65 | 71 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 5.73e-04 | 67 | 71 | 3 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 5.98e-04 | 68 | 71 | 3 | EFO_0022144 | |
| Disease | joint damage measurement | 5.98e-04 | 68 | 71 | 3 | EFO_0005413 | |
| Disease | Urticaria | 6.70e-04 | 16 | 71 | 2 | C0042109 | |
| Disease | nephrotic syndrome | 6.79e-04 | 71 | 71 | 3 | EFO_0004255 | |
| Disease | Manic Disorder | 6.79e-04 | 71 | 71 | 3 | C0024713 | |
| Disease | anti-anoctamin 2 antibody measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0010150 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0010559, GO_0035456 | |
| Disease | late-onset myasthenia gravis | 8.52e-04 | 18 | 71 | 2 | EFO_1001490 | |
| Disease | Manic | 8.92e-04 | 78 | 71 | 3 | C0338831 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 8.92e-04 | 78 | 71 | 3 | EFO_0022187 | |
| Disease | Depression, Bipolar | 9.26e-04 | 79 | 71 | 3 | C0005587 | |
| Disease | non-alcoholic fatty liver disease | 9.86e-04 | 182 | 71 | 4 | EFO_0003095 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.14e-03 | 85 | 71 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | Schizophrenia | 1.25e-03 | 883 | 71 | 8 | C0036341 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.28e-03 | 22 | 71 | 2 | EFO_0021881 | |
| Disease | Henoch-Schoenlein purpura | 1.28e-03 | 22 | 71 | 2 | EFO_1000965 | |
| Disease | retinal vasculature measurement | 1.54e-03 | 517 | 71 | 6 | EFO_0010554 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.63e-03 | 713 | 71 | 7 | EFO_0005689 | |
| Disease | Acute Confusional Senile Dementia | 1.77e-03 | 99 | 71 | 3 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.77e-03 | 99 | 71 | 3 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.77e-03 | 99 | 71 | 3 | C0750901 | |
| Disease | Presenile dementia | 1.77e-03 | 99 | 71 | 3 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 1.77e-03 | 99 | 71 | 3 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.83e-03 | 100 | 71 | 3 | C0276496 | |
| Disease | Alzheimer's Disease | 1.88e-03 | 101 | 71 | 3 | C0002395 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.99e-03 | 103 | 71 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.04e-03 | 222 | 71 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.14e-03 | 225 | 71 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | familial hyperlipidemia | 2.16e-03 | 106 | 71 | 3 | MONDO_0001336 | |
| Disease | phospholipids:total lipids ratio | 2.21e-03 | 227 | 71 | 4 | EFO_0020946 | |
| Disease | Epileptic encephalopathy | 2.38e-03 | 30 | 71 | 2 | C0543888 | |
| Disease | intellectual disability (is_implicated_in) | 2.38e-03 | 30 | 71 | 2 | DOID:1059 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGLDLPMKVVDMFGC | 371 | Q9BT22 | |
| VGGCLLSLMPHFKSM | 316 | Q15052 | |
| MKGTGIMDCAPKALL | 1 | Q9NQ75 | |
| VGGCFLNLMPQMKTL | 346 | Q14155 | |
| GSKPMMDLLIFLCAQ | 76 | Q53SF7 | |
| SMMIPLCRDFGGLIV | 401 | P36021 | |
| AFLKMKMTFCPGLVD | 81 | Q9H4I0 | |
| RLPLCGKAFADMMGK | 36 | O60896 | |
| KMMGVPLQCSALLVR | 396 | Q05329 | |
| MVCLKLPGGSYMAKL | 1 | Q30154 | |
| CIMGEMVRHKILFPG | 251 | P53779 | |
| RAGIGLPKMCLHMAV | 51 | Q6ZUU3 | |
| CMQEFMDKKLPGIIG | 31 | P50135 | |
| PCGIMDQFISLMGQK | 181 | P51570 | |
| DNMVMACGGILPLLS | 1366 | P50851 | |
| VVGLCLMGMGVYKIR | 391 | Q9UQV4 | |
| DKAAALMCGVFIPML | 271 | O60431 | |
| MACGLGGKLVLPMIK | 346 | O00410 | |
| LGFCKPEAMMSGSIV | 796 | Q6XUX3 | |
| MGFLVLGLVPFLMIC | 556 | Q02413 | |
| MAIHKALVMCLGLPL | 1 | Q9NQ84 | |
| WLIPGMDKGLLGMCV | 201 | O95302 | |
| VFVGMCLRRLGLSPM | 306 | Q9C0J1 | |
| CKGMPLSSFILKPMQ | 1366 | Q15811 | |
| MVCLKLPGGSCMTAL | 1 | P01911 | |
| NKMTPLRIALMLGGC | 131 | Q13639 | |
| GMLCMPKGLAFKTQA | 96 | Q6IQ26 | |
| FPFIGGMLQALITAM | 371 | P48664 | |
| MVCLKLPGGSCMAAL | 1 | P13762 | |
| MAMGVPRVILLCLFG | 1 | Q6UWN5 | |
| PKYCSMMILLTAGLG | 201 | Q5T6L9 | |
| VLISMQLMSGDPCFK | 136 | Q5T8I3 | |
| AMKMELLGCQFIPKG | 441 | Q96PD2 | |
| GMIQRKMCILFSKPL | 5421 | Q8NDH2 | |
| GLLAQRMFVMLPCGG | 606 | Q8WUI4 | |
| LSVTVALGCMFTPKM | 821 | Q13255 | |
| CKLLPSALQKMALGM | 401 | Q8IY34 | |
| TLCFGMLRGFLMTLP | 2726 | Q8TDX9 | |
| GKQPLLSMCLTIMVG | 446 | P36268 | |
| GKMVSLFCGIIAPML | 271 | Q9GZK3 | |
| CEILMMVGLPAAGKT | 421 | Q9BUJ2 | |
| GVLCAMGIIIVMSAK | 46 | Q14802 | |
| IGKIFMFNVCGTMPV | 961 | P11717 | |
| KIGVMVCVGIMAACP | 276 | P59533 | |
| MLGFLSRGPSMKLCM | 1 | C9JL84 | |
| FLMGLVGFMICHVLK | 26 | Q8NC24 | |
| MAHGPGALMLKCVVV | 1 | P17081 | |
| KCLIGQKFMPVEGMV | 396 | Q9UGI8 | |
| FSSVISMAKPIGLCM | 206 | Q96KN7 | |
| CIIMGIPMNIGTGLF | 1346 | O14802 | |
| MGPLSLLVMGFIACH | 86 | Q495M3 | |
| MAPLGMLLGLLMAAC | 11 | Q9H173 | |
| KGSTLMAGFLKLLPM | 296 | P53794 | |
| MGLGCFLKSLPHFLM | 96 | P46721 | |
| LAAIPGYMVLLRCMK | 526 | P46721 | |
| KFMTMVLGIGPVLGL | 51 | Q96JT2 | |
| FPAMLCKMGFAVLLV | 521 | P13798 | |
| IPKGFMDGKQACILM | 736 | P35749 | |
| MPGGACVLVIALMFL | 1 | Q8N2E2 | |
| PILGGMFCTLFGMIT | 426 | Q9UHI7 | |
| LGVASCLLMMFLISP | 461 | Q9BXP2 | |
| KYGMGGMIIVLLICI | 2401 | Q9H5I5 | |
| CRLMSGILAVGPMFV | 191 | Q9BY14 | |
| QGLVPCVMFVLKEML | 701 | Q5SRE5 | |
| MSAMNIKLGPALKIC | 981 | P78364 | |
| RMCGFLSLQIMGPLI | 156 | Q8WVE6 | |
| VMAPNLFMCHALGLK | 481 | Q8N392 | |
| VRSAGGPMCFLMLTL | 596 | Q8TE23 | |
| VPALKGLGECHLMMA | 666 | Q6PGP7 | |
| MCVLASIIVVGLKGM | 406 | Q8TE54 | |
| VAKGQPLCVLSAMKM | 1131 | P11498 | |
| PDVGHVLRMLLGKMC | 501 | Q8TD43 | |
| GMVCPLIVGAMTRHK | 461 | Q8NDX2 | |
| GMILFCMAALIFPIG | 106 | Q8NHV5 | |
| IMGLFDGCFISIMAP | 391 | Q8TF71 |